Keyphrases
Bacterial Infection
100%
Multidrug-resistant Gram-negative Bacteria
100%
Novel Antibiotics
100%
Acute Care Setting
33%
Acute Care
33%
Public Health
16%
Clinical Information
16%
Antimicrobial Resistance
16%
Infection Treatment
16%
Gram-negative Organisms
16%
Omadacycline
16%
Imipenem
16%
Eravacycline
16%
Cefiderocol
16%
Ceftolozane-tazobactam
16%
Meropenem-vaborbactam
16%
Plazomicin
16%
Ceftazidime-avibactam
16%
Relebactam
16%
Medicine and Dentistry
Gram-Negative Bacterial Infection
100%
Antibiotics
100%
Emergency Care
66%
Infection
33%
Gram-Negative Bacteria
33%
Antibiotic Resistance
16%
Public Health
16%
Meropenem
16%
Omadacycline
16%
Imipenem
16%
Cefiderocol
16%
Tazobactam
16%
Ceftolozane
16%
Plazomicin
16%
Eravacycline
16%
Relebactam
16%
Vaborbactam
16%
Avibactam Plus Ceftazidime
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotics
100%
Gram Negative Infection
100%
Infection
33%
Gram Negative Bacterium
33%
Antimicrobial Resistance
16%
Imipenem
16%
Meropenem
16%
Omadacycline
16%
Cefiderocol
16%
Tazobactam
16%
Ceftolozane
16%
Avibactam Plus Ceftazidime
16%
Vaborbactam
16%
Plazomicin
16%
Relebactam
16%
Eravacycline
16%